Increasing frontline covalent BTK inhibitor use and emerging BTKi+BCL2i+anti-CD20 triplets constrain the R/R BTK-naïve ...
Recent data from the National Cancer Institute (NCI) suggest that the number of people in the US diagnosed with diffuse large ...
Patients suffering from acute myeloid leukemias (AML) bearing FMS-like tyrosine kinase-3-internal tandem duplications (FLT3-ITD) have poor outcomes following cytarabine- and anthracyclin-based ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results